Crizanlizumab is under clinical development by Novartis and currently in Phase II for Chronic Kidney Disease (Chronic Renal Failure). According to GlobalData, Phase II drugs for Chronic Kidney Disease ...

Lufepirsen is under clinical development by Amber Ophthalmics and currently in Phase II for Persistent Corneal Epithelial Defects. According to GlobalData, Phase II drugs for Persistent Corneal ...

Based on the thermal-elastic mechanism, the finite element model for laser ultrasound inspection of aluminum materials containing surface defects was developed by using the finite element software ...

A class action lawsuit filed last month by some Toyota truck owners deals with a defect in the engines - some made in Huntsville - for the Tundra pickup. The suit, filed in U.S. District Court in ...

Bionics Research Center, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul 02447, ...

OBJECTIVES: We evaluated the validity and reliability of ultrasonography measurement of rectus femoris cross-sectional area compared to computed tomography in patients in pre-dialysis chronic kidney ...

This may include the following non-surgical or surgical methods: passing a kidney stone at home, shock wave lithotripsy (a procedure that uses ultrasound energy to break a kidney stone into smaller ...